Artis BioSolutions
Provider of an integrated platform combining cell-free enzymatic synthetic DNA production with process and analytical development, CMC strategy, and GMP manufacturing for advanced therapies. Operates manufacturing and development sites in the US and EU and supports viral vectors, cell therapies, mRNA/LNP, extracellular vesicles, and related modalities from starting material through clinical supply.
Industries
Biotechnology
Biotechnology Research
Nr. of Employees
medium (51-250)
Artis BioSolutions
Expertise Areas
- Synthetic DNA manufacturing
- Viral vector development and GMP manufacturing
- Cell therapy process development and clinical manufacturing
- Analytical development and GMP-aligned testing
Key Technologies
- Cell-free enzymatic synthetic DNA
- In vitro transcription (IVT) template optimization
- HEK293 suspension bioreactor processing
- Chromatography and tangential flow filtration (TFF)